Ciphergen Releases Q2 Results, New Name
Ciphergen Biosystems Inc. (NASDAQ: CIPH) reported its second quarter results for 2007 today, prompting the company's share prices to rise 10.2 percent to 75 cents a share. The company managed to reduce its total operating expenses for the second quarter of 2007, dropping expenses from $9.5 million last year to $5.9 million this year. Ciphergen attributed this reduction to the "elimination of selling and marketing expenses associated with the company's former life sciences tools business," which the company recently sold to Bio-Rad Laboratories. Unfortunately, since the company sold off its life sciences research business, the company cut off its revenue…